CDC updates opioid prescribing guidelines for clinicians
The Centers for Disease Control and Prevention today released for clinicians prescribing opioids to outpatients for short- or long-term pain, which replace guidelines released in 2016.
鈥淭he science on pain care has advanced over the past six years,鈥 said Debbie Dowell, M.D., chief clinical research officer for CDC鈥檚 Division of Overdose Prevention. 鈥淒uring this time, CDC has also learned more from people living with pain, their caregivers, and their clinicians. We鈥檝e been able to improve and expand our recommendations by incorporating new data with a better understanding of people鈥檚 lived experiences and the challenges they face when managing pain and pain care.鈥
Related News Articles
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to鈥
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,鈥
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to鈥
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and鈥
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from鈥
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and鈥